SCHEMBL301247

SCHEMBL301247

Cc1cccc(-c2cccc(C)c2)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.69
RAB9A P51151 2/20 0.54
ALDH1A1 P00352 2/20 0.52
MAPK1 P28482 1/20 0.52
NPC1 O15118 1/20 0.52
HPGD P15428 1/20 0.52
TSHR P16473 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
ENPP3 O14638 1/20 0.50
IDO1 P14902 1/20 0.50
METAP2 P50579 1/20 0.50
PTPN5 P54829 1/20 0.48
NISCH Q9Y2I1 1/20 0.48
CHRNB4 P30926 1/20 0.48
CHRNA3 P32297 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
MAP4K4 O95819 1/20 0.47
DHODH Q02127 1/20 0.47
AR P10275 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29373699 1.00 ACHE (0.69) ACHERAB9AALDH1A1MAPK1NPC1
SCHEMBL31471473 1.00 ACHE (0.69) ACHERAB9AALDH1A1MAPK1NPC1
SCHEMBL19577801 0.97 ACHE (0.65) ACHERAB9AALDH1A1MAPK1NPC1
SCHEMBL18797759 0.97 ACHE (0.65) ACHERAB9AALDH1A1MAPK1NPC1
Hydrazine SCHEMBL29067501 0.94 ACHE (0.61) ACHERAB9AALDH1A1MAPK1NPC1
SCHEMBL28043529 0.94 ACHE (0.61) ACHERAB9AALDH1A1MAPK1NPC1
SCHEMBL6561397 0.94 ACHE (0.61) ACHERAB9AALDH1A1MAPK1NPC1
SCHEMBL30443064 0.94 ACHE (0.61) ACHERAB9AALDH1A1MAPK1NPC1
SCHEMBL29699277 0.91 ACHE (0.58) ACHERAB9AALDH1A1MAPK1NPC1
SCHEMBL200730 0.91 ACHE (0.58) ACHERAB9AALDH1A1MAPK1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 716 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250163224-A1 POLYMER AND PREPARATION METHOD THEREFOR, AND ANION-EXCHANGE MEMBRANE Tan Kah Kee Innovation Laboratory (CN) 2025-05-22 US claimed
US-12297327-B1 Polymer and preparation method therefor, and anion-exchange membrane Tan Kah Kee Innovation Laboratory (CN) 2025-05-13 US claimed
EP-4529548-A1 RECYCLING POLYOLS PRODUCED FROM MOLDED POLYURETHANE FOAM FAURECIA Sièges d'Automobile (FR) 2025-04-02 EP claimed
EP-4529547-A1 RECYCLING POLYOLS PRODUCED FROM SEAT COVER MATERIALS FAURECIA Sièges d'Automobile (FR) 2025-04-02 EP claimed
EP-3290481-B1 POLYAMIDEIMIDE RESIN COMPOSITION AND COATING MATERIAL RESONAC CORP (JP) 2024-09-11 EP claimed
US-20240252991-A1 CROWN ETHER MODIFIED CATION EXCHANGE MEMBRANES FOR SELECTIVE RECOVERY OF IONIC SPECIES AND METHODS OF MAKING AND USING THE SAME U.S. DEPARTMENT OF ENERGY 2024-08-01 US claimed
EP-4377369-A1 METHOD FOR PRODUCING A MIXTURE OF ALKOXYLATED POLYPHENOLS AND USE OF SAID MIXTURE SOPREMA (FR) 2024-06-05 EP claimed
CN-117059804-B Chemical pre-lithium agent, lithium ion battery and preparation method of lithium ion battery 瑞浦兰钧能源股份有限公司 2024-03-19 CN claimed
US-11879039-B1 Preparation method for thermoplastic multi-hybrid polyimide films HARBIN ENGINEERING UNIVERSITY (CN) 2024-01-23 US claimed
WO-2023227840-A1 RECYCLING POLYOLS PRODUCED FROM MOLDED POLYURETHANE FOAM Faurecia Sièges d'Automobile (FR) 2023-11-30 WO claimed
CN-102227411-B Antimicrobial compounds SUMMIT Corp.,PLC (GB) 2015-10-14 CN claimed
CN-103025383-B Compounds for the treatment of clostridium difficile-associated diseases SUMMIT CORP PLC 2015-03-25 CN claimed
EP-2764030-B1 DISPERSIONS, PROCESS FOR PREPARING DISPERSIONS, INKS AND USES FUJIFILM IMAGING COLORANTS LTD (GB) 2014-12-03 EP claimed
US-20140042369-A1 Organic Semiconductor Formulations USINVEST LLC 2014-02-13 US claimed
WO-2013173332-A1 METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN Vertichem Corporation (CA) 2013-11-21 WO claimed
US-20130232853-A1 METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN THESIS CHEMISTRY, LLC (US) 2013-09-12 US claimed
CN-103025383-A Compounds for the treatment of clostridium difficile-associated diseases SUMMIT CORP PLC 2013-04-03 CN claimed
US-20080182188-A1 base media, at least one sub-layer formed on a first side of the base media, and an image receiving layer includes a cross-linked resin coating structure HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2008-07-31 US claimed
WO-2001039844-A1 GOLF BALL COMPRISING WATER RESISTANT POLYURETHANE ELASTOMERS AND METHODS OF MAKING THE SAME ACUSHNET COMPANY (US) 2001-06-07 WO claimed
US-4568715-A Aromatic polyimide composition comprising mixed solvent UBE INDUSTRIES, LTD. (JP) 1986-02-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130232853-A1 METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN HAAO, HAO2, HACL2 ACHE 1478/4885RAB9A 3023/4885ALDH1A1 166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.